Re: Glucose fluctuation
|
3
|
Resverlogix Corp.
|
Jun 15, 2015 08:24AM
|
Re: No investor forum is an island.....trying to get Joe_Retail back on SH
|
3
|
Resverlogix Corp.
|
Jul 10, 2015 06:33PM
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 12, 2021 05:23PM
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 22, 2017 04:44PM
|
Re: Don's Milestones/ Major Achievements at RVX
|
3
|
Resverlogix Corp.
|
Sep 02, 2022 07:58PM
|
Re: Potential
|
3
|
Zenith Epigenetics
|
Jul 21, 2021 10:41AM
|
Re: Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial
|
3
|
Resverlogix Corp.
|
Jul 10, 2017 03:20PM
|
Re: Cash
|
3
|
Zenith Epigenetics
|
Oct 07, 2019 05:22AM
|
More on Ms Biln - from F6 Investor Village
|
3
|
Resverlogix Corp.
|
Apr 05, 2016 04:52PM
|
Re: ... removed posts????
|
3
|
Resverlogix Corp.
|
Oct 30, 2017 10:58AM
|
Re: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Aug 29, 2017 04:14PM
|
Re: Hepalink Anniversary - Apr 27
|
3
|
Resverlogix Corp.
|
Apr 26, 2016 01:34PM
|
Re: Zenith Materials - Beyond Website
|
3
|
Resverlogix Corp.
|
Sep 29, 2015 01:22PM
|
Re: News out, we're debt free
|
3
|
Resverlogix Corp.
|
Dec 06, 2017 07:46PM
|
Re: WORLD DIABETES DAY New RVX Blog Post 11/18/15
|
3
|
Resverlogix Corp.
|
Nov 19, 2015 02:23PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
3
|
Resverlogix Corp.
|
Dec 10, 2015 04:48PM
|
Re: Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardio Benefits at Euro Society of Cardiology Congress 2024
|
3
|
Resverlogix Corp.
|
Sep 03, 2024 09:59PM
|
Re: "Later this quarter we'll announce some orphan indications that we'll be going..
|
3
|
Resverlogix Corp.
|
Jul 15, 2015 12:37PM
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Sep 18, 2017 01:28PM
|
Re: The MD@A for the period ending July 31, 2017
|
3
|
Resverlogix Corp.
|
Sep 15, 2017 01:21PM
|